官方服务：
资源简介：
Supplemental Table 1 for, "Methotrexate for pyoderma gangrenosum: a retrospective case series of 33 patients"
应用场景：
创建时间：
2023-10-31
相关数据集
Methotrexate for PG: Supplemental Table
Supplemental Table for the article, "Methotrexate for pyoderma gangrenosum: a retrospective case series of 33 patients" by Josiah A. Williams, MD; Matthew L. Hrin, MD; Nathan L. Bowers, MD, PhD; Josep
Mendeley Data2024-01-31 更新160
Methotrexate for PG: Supplemental Table
Supplemental Table for the article, "Methotrexate for pyoderma gangrenosum: a retrospective case series of 33 patients" by Josiah A. Williams, MD; Matthew L. Hrin, MD; Nathan L. Bowers, MD, PhD; Josep
Mendeley Data50
Supplementary Material for: Adalimumab and Tofacitinib Combination Therapy for Pyoderma Gangrenosum: A case report
Introduction: Pyoderma gangrenosum (PG) is a rare inflammatory skin disease causing progressive necrotizing ulcers with limited treatment options due to adverse effects and high recurrence rates. Case
NIAID Data Ecosystem10
DataSheet_1_Methotrexate Inhibits T Cell Proliferation but Not Inflammatory Cytokine Expression to Modulate Immunity in People Living With HIV.pdf
Inflammation associated with increased risk of comorbidities persists in people living with HIV (PWH) on combination antiretroviral therapy (ART). A recent placebo-controlled trial of low-dose methotr
NIAID Data Ecosystem60
Heterogeneous Response to Spesolimab in Pyoderma Gangrenosum Depends on Underlying Myeloid Disorders-supplymentary files
supplymentary files for brief report "Heterogeneous Response to Spesolimab in Pyoderma Gangrenosum Depends on Underlying Myeloid Disorders"
NIAID Data Ecosystem20
